(S)-TERT-BUTYL (1-(PYRROLIDIN-3-YL)CYCLOPROPYL)CARBAMATE, 95.0%, 1g

5,6-Dihydro-1,4-dithiin-2,3-dicarboxylic Anhydride>98.0%(GC)1g

DNP-PEG3-azide, 250mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid, 97%, 100mg

9-(Tetrahydro-2H-pyran-2-yl)-9H-purin-6-amine, 95.0%, 100mg

2-{[(2-fluorophenyl)sulfonyl]amino}-4-(methylthio)butanoic acid, 95.0%, 2.5g

N-Methoxy-N-methylbenzamide, 98.0%, 1g

Tripropyl phosphate, 95.0%, 25g

S-(2-(N-((4-Amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl)benzothioa, 95.0%, 5g

2,7-Diamino-9H-fluoren-9-one, 97%, 5g

Salmeterol Xinafoate>98.0%(HPLC)(T)1g

METHYL 3-(HYDROXYMETHYL)-5-NITROBENZOATE, 95%, 100mg

Vanillic acid, min. 98%, 10 g, plastic packaging.